Skip to content

LivaNova LIVN Gross margin

Gross margin at other companies

Abbott logo
AbbottABT
56.3%+0.4pp
Haemonetics logo
HaemoneticsHAE
59%+4.0pp
Medtronic logo
MedtronicMDT
65%-0.3pp
ResMed logo
ResMedRMD
61.6%+2.8pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Stryker logo
StrykerSYK
63.8%-0.1pp

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on trailing twelve months.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's gross margin?
LivaNova (LIVN) reported gross margin of 67.5% in Q1 2026.
How has LivaNova's gross margin changed year-over-year?
LivaNova's gross margin decreased by 0.7% year-over-year, from 67.9% to 67.5%.
What is the long-term trend for LivaNova's gross margin?
Over 5 years (2020 to 2025), LivaNova's gross margin has grown at a 0.9% compound annual growth rate (CAGR), from 64.7% to 67.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.